1、Sheng J#, Zhang J#, Wang L, Tano V, Tang JH Wang X, Wu J, Song J, Zhao Y, Rong J, Cheng F, Wang J, Shen Y, Wen L, He J, Zhang H, Li T, Zhang Q, Bai X, Lu Z, Liang TB (梁廷波)*. Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny. Gut2021（IF=23.059）
2、Zhang Q#, Lou Y#, Yang JQ#, Wan, JL, Feng J, Zhao YL, Wang L, Huang X, Fu QH, Ye M, Zhang XZ, Chen YW, Ma C, Ge HB, Wang JN, Wu JC, Wei T, Chen Q, Wu JQ, Yu CX, Xiao YY, Feng XH, Guo GJ, Liang TB (梁廷波)*, Bai XL*. Integrated multiomic analysis reveals comprehensive tumor heterogeneity and novel immunophenotypic classification in hepatocellular carcinoma. Gut. 2019（IF=23.059）3、Zhang X#, Huang X#*, Xu J, Li E, Lao M, Tang T, Zhang G, Guo C Zhang X, Chen W, Yadav DK, Bai X*, Liang T (梁廷波)*. NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Nat Commun. 2021;12(1):4536.（IF=14.919）
4、Meng F, Yu Z, Zhang D, Chen S, Guang H, Zhou R, Wu Q, Zhang Q, Liu S, Venkat Ramani MK, Yang B, Ba XQ, Zhang J, Huang J, Bai X, Qin J, Feng XH, Ouyang S, Zhang YJ, Liang T (梁廷波)*, Xu P*. Induced phase separatino of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell. 2021;81(20):4147-4164. （IF=17.97）
5、Zhang JY#, Zhang Q#, Lou Y, Fu QH, Chen Q, Wei T, Yang JQ, Tang JL, Wang JX, Chen YW, Zhang XY, Zhang J, Bai XL*, Liang TB (梁廷波)*. HIF-1α/IL-1β signaling enhances hepatoma epithelial-mesenchymal transition via macrophages in a hypoxic-inflammatory microenvironment. Hepatology. 2018;（IF=17.425）
6、Xu X#, Ye L#, Zhang Q#, Shen H, Li S, Zhang X, Ye M, Liang TB (梁廷波)*. Group-2 innate lymphoid cells promote HCC progression through CXCL2-neutrophil-induced immunosuppression. Hepatology. 2021（IF=17.425）
7、Huang X#*, Xu XY#, Wang X, Tang TY, Li EL, Zhang XZ, Xu J, Shen H, Guo CX, Xu T, Ren JH, Bai XL*, Liang TB (梁廷波)*. The AKT-independent MET–V-ATPase–MTOR axis suppresses liver cancer vaccination. S
